March 2016

Researchers at the University of Pittsburgh School of Medicine and Arts and Sciences say they have designed a more potent version of the FDA-approved epilepsy drug retigabine. A study published on March 22, 2016 in Molecular Pharmacology compares RL648_81 (RL-81), the experimental agent developed by Pitt researchers, with retigabine, and SF0034, a KCNQ2/3 activator being […]

by

Getty As medical marijuana becomes legal in more states across the country, there’s been a spike in public interest to see whether cannabis can effectively treat mood disorders such as anxiety, depression, and psychosis that are commonly associated with bipolar disorder. Unfortunately, there are conflicts in scientific consensus for both supporting and opposing views of […]

by

Medical Marijuana Inc (OTCMKTS:MJNA) has so far trailed other pot stocks in 2016. However, this could change pretty quick as Medical Marijuana Inc is one of best known names among pot stock enthusiasts. We think this is more likely than not as a new marijuana Green Rush looks to be starting. We’ve been talking about […]

by

Notis Global Inc (OTCMKTS:NGBL) has a new name and a new symbol as it looks to erase the stench that was Medbox Inc. Medbox left investors with large losses as the company went on a wave of dilution and socked it to the average investor. As Notis Global, the company is hoping that it can […]

by

Monday, cannabis industry leader, GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) announced positive results from its first Phase 3 study of Epidiolex in the treatment of Dravet syndrome.  Epidiolex already has orphan drug designation and Fast Track Designation from the FDA for this rare form of epilepsy.  Currently there are no treatments approved in the U.S.   The […]

by

February 25, 2016 Exosomal Tau Blood Test May Detect CTE in the Living Researchers may have uncovered a way to detect chronic traumatic encephalopathy (CTE) in living individuals with a blood test that detects plasma exosomal tau. The preliminary results were published in the Journal of Alzheimer’s Disease. A definitive diagnosis of CTE has previously […]

by

February 17, 2016 Patients On HRT See Stroke Risk Increase with Migraine Severity LOS ANGELES — Women on hormone replacement therapy (HRT) who experience an increase in migraine severity of one grade or more are at increased risk for ischemic stroke, according to study results presented here at the 2016 International Stroke Conference. “We found […]

by